Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical and functional characterization of CXCR1/CXCR2 biology in the relapse and radiotherapy resistance of primary PTEN-deficient prostate carcinoma.
Armstrong CWD, Coulter JA, Ong CW, Maxwell PJ, Walker S, Butterworth KT, Lyubomska O, Berlingeri S, Gallagher R, O'Sullivan JM, Jain S, Mills IG, Prise KM, Bristow RG, LaBonte MJ, Waugh DJJ. Armstrong CWD, et al. Among authors: labonte mj. NAR Cancer. 2020 Sep;2(3):zcaa012. doi: 10.1093/narcan/zcaa012. Epub 2020 Jul 3. NAR Cancer. 2020. PMID: 32743555 Free PMC article.
PTEN deficiency promotes macrophage infiltration and hypersensitivity of prostate cancer to IAP antagonist/radiation combination therapy.
Armstrong CW, Maxwell PJ, Ong CW, Redmond KM, McCann C, Neisen J, Ward GA, Chessari G, Johnson C, Crawford NT, LaBonte MJ, Prise KM, Robson T, Salto-Tellez M, Longley DB, Waugh DJ. Armstrong CW, et al. Among authors: labonte mj. Oncotarget. 2016 Feb 16;7(7):7885-98. doi: 10.18632/oncotarget.6955. Oncotarget. 2016. PMID: 26799286 Free PMC article.
The Unfolded Protein Response: A Novel Therapeutic Target for Poor Prognostic BRAF Mutant Colorectal Cancer.
Forsythe N, Refaat A, Javadi A, Khawaja H, Weir JA, Emam H, Allen WL, Burkamp F, Popovici V, Jithesh PV, Isella C, Labonte MJ, Mills IG, Johnston PG, Van Schaeybroeck S. Forsythe N, et al. Among authors: labonte mj. Mol Cancer Ther. 2018 Jun;17(6):1280-1290. doi: 10.1158/1535-7163.MCT-17-0603. Epub 2018 Feb 26. Mol Cancer Ther. 2018. PMID: 29483217 Free PMC article.
Attenuating Adaptive VEGF-A and IL8 Signaling Restores Durable Tumor Control in AR Antagonist-Treated Prostate Cancers.
Maxwell PJ, McKechnie M, Armstrong CW, Manley JM, Ong CW, Worthington J, Mills IG, Longley DB, Quigley JP, Zoubeidi A, de Bono JS, Deryugina E, LaBonte MJ, Waugh DJJ. Maxwell PJ, et al. Among authors: labonte mj. Mol Cancer Res. 2022 Jun 3;20(6):841-853. doi: 10.1158/1541-7786.MCR-21-0780. Mol Cancer Res. 2022. PMID: 35302608 Free PMC article.
Targeting nucleotide metabolism enhances the efficacy of anthracyclines and anti-metabolites in triple-negative breast cancer.
Davison C, Morelli R, Knowlson C, McKechnie M, Carson R, Stachtea X, McLaughlin KA, Prise VE, Savage K, Wilson RH, Mulligan KA, Wilson PM, Ladner RD, LaBonte MJ. Davison C, et al. Among authors: labonte mj. NPJ Breast Cancer. 2021 Apr 6;7(1):38. doi: 10.1038/s41523-021-00245-5. NPJ Breast Cancer. 2021. PMID: 33824328 Free PMC article.
54 results